在 Ústí nad Labem (Aussig) 的 Norgine 制药公司
概括
诺吉恩公司成立于1909年,从生产藻酸盐发展到开发Normacol和Pyralvex等关键药品. 该公司经历了重要的历史事件,在全球范围内延续其制药遗产.
科学领域:
- 制药历史 制药历史
- 化学制造业 化学制造业 化学制造业
- 公司 公司进化 公司进化
背景情况:
- 诺吉因于1909年由维克多·斯坦 (Victor Stein) 创立,最初生产酸和海藻衍生化学制剂.
- 早期的诺基因产品包括长期存在的药Normacol和瘤痛Pyralvex.
- 第一次世界大战后,诺吉内将重点转移到制药,特别是胰岛素,并与布拉格大学的药理学家合作.
研究的目的:
- 为了记录制药公司Norgine的历史轨迹.
- 记录Norgine的产品开发及其通过历史和地缘政治变化的适应.
- 为了突出Norgine的弹性和作为全球制药实体的持续运营.
主要方法:
- 对Norgine的创立和早期运营进行历史分析.
- 审查Norgine产品组合的发展,包括关键药物.
- 考察Norgine公司的企业历程,通过重大历史事件,包括国有化和私有化.
主要成果:
- 诺吉因在酸和早期制药方面取得的初步成功为其未来奠定了基础.
- 该公司的产品组合扩大到包括胰岛素,抗药 (Apasmon) 和抗贫血药 (Ferrostabil).
- 尽管所有权发生了变化,战争中断,国有化 (作为SPOFA/Chemopharm) 和私有化,但诺吉恩的制药业务在1945年后继续在国外运营.
结论:
- 诺吉恩的历史表明,它始终专注于制药创新和适应.
- 该公司成功地驾了复杂的历史时期,保持了其核心业务.
- 诺吉因的持久存在强调了其战略性和全球制药市场的可行性.
相关概念视频
01:26Pharmaceutical Equivalents
190
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
190
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
181
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
181
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
425
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
425
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
178
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
178
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
160
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
160
01:29Fermentation
128.9K
Most eukaryotic organisms require oxygen to survive and function adequately. Such organisms produce large amounts of energy during aerobic respiration by metabolizing glucose and oxygen into carbon dioxide and water. However, most eukaryotes can generate some energy in the absence of oxygen by anaerobic metabolism.
Fermentation is a type of metabolic process that occurs in the absence of oxygen, where organic molecules such as glucose are broken down to produce energy. During this process, the...
Fermentation is a type of metabolic process that occurs in the absence of oxygen, where organic molecules such as glucose are broken down to produce energy. During this process, the...
128.9K